Parallel Advisors, LLC Esperion Therapeutics, Inc. Transaction History

Parallel Advisors, LLC

  • $5.28 Billion
  • Q3 2025

A detailed history of Parallel Advisors, LLC transactions in Esperion Therapeutics, Inc. stock. As of the latest transaction made, Parallel Advisors, LLC holds 117,424 shares of ESPR stock, worth $340,529. This represents 0.01% of its overall portfolio holdings.

Number of Shares
117,424
Previous 127,424 7.85%
Holding current value
$340,529
Previous $124,000 150.81%
% of portfolio
0.01%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025
SELL
$0.98 - $2.84 $9,800 - $28,400
-10,000 Reduced 7.85%
117,424 $311,000
Q2 2025

Jul 07, 2025
BUY
$0.73 - $1.41 $85,719 - $165,567
117,424 Added 1174.24%
127,424 $124,000
Q4 2024

Feb 10, 2025
SELL
$1.61 - $3.83 $376,740 - $896,220
-234,000 Reduced 95.9%
10,000 $22,000
Q3 2024

Nov 13, 2024
BUY
$1.61 - $2.73 $8,050 - $13,650
5,000 Added 2.09%
244,000 $402,000
Q1 2024

May 06, 2024
SELL
$2.02 - $3.02 $482,780 - $721,780
-239,000 Reduced 50.0%
239,000 $640,000
Q3 2023

May 20, 2024
BUY
$0.96 - $1.79 $458,717 - $855,317
477,831 Added 282740.25%
478,000 $468,000
Q3 2023

Nov 13, 2023
BUY
$0.96 - $1.79 $458,880 - $855,620
478,000 New
478,000 $468,000
Q1 2023

May 20, 2024
SELL
$1.46 - $7.3 $348,693 - $1.74 Million
-238,831 Reduced 99.93%
169 $0
Q1 2023

Apr 25, 2023
BUY
$1.46 - $7.3 $246 - $1,233
169 New
169 $0
Q3 2022

Nov 10, 2022
BUY
$5.45 - $8.13 $98 - $146
18 Added 51.43%
53 $0
Q2 2022

Aug 01, 2022
BUY
$4.77 - $6.67 $166 - $233
35 New
35 $0
Q1 2022

Apr 28, 2022
SELL
$3.34 - $5.56 $5,096 - $8,484
-1,526 Closed
0 $0
Q4 2021

Jan 20, 2022
BUY
$4.81 - $11.92 $6,733 - $16,688
1,400 Added 1111.11%
1,526 $8,000
Q3 2021

Nov 02, 2021
BUY
$11.34 - $21.37 $1,406 - $2,649
124 Added 6200.0%
126 $2,000
Q1 2021

Apr 23, 2021
SELL
$25.12 - $36.89 $75 - $110
-3 Reduced 60.0%
2 $0
Q4 2020

Feb 02, 2021
SELL
$24.2 - $35.76 $121 - $178
-5 Reduced 50.0%
5 $0
Q3 2020

Oct 27, 2020
BUY
$31.18 - $52.71 $311 - $527
10 New
10 $0
Q2 2020

Jul 16, 2020
SELL
$30.04 - $51.31 $532,008 - $908,700
-17,710 Closed
0 $0
Q4 2019

Jan 30, 2020
BUY
$35.4 - $59.82 $354,000 - $598,200
10,000 Added 129.7%
17,710 $1.06 Million
Q3 2019

Nov 01, 2019
BUY
$34.47 - $47.53 $265,763 - $366,456
7,710 New
7,710 $283,000
Q2 2019

Aug 05, 2019
SELL
$40.1 - $52.33 $80,200 - $104,660
-2,000 Closed
0 $0
Q1 2019

May 01, 2019
BUY
$40.11 - $53.57 $80,220 - $107,140
2,000 New
2,000 $80,000

Others Institutions Holding ESPR

# of Institutions
215
Shares Held
113M
Call Options Held
643K
Put Options Held
769K
View Full List

About Esperion Therapeutics, Inc.

ESPR Quotes by TradingView
  • Ticker ESPR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,551,600
  • Market Cap $193M
  • Description
  • Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...
More about ESPR
Track This Portfolio

Track Parallel Advisors, LLC Portfolio

Follow Parallel Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email